EPISODE · Apr 27, 2020 · 10 MIN
Q BioMed Inc. Discusses The Commercialization of Its FDA Approved Metastatic Bone Pain Drug with The Stock Day Podcast
from Stock Day Media · host Stock Day Media
The Stock Day Podcast welcomed Q BioMed Inc. (QBIO)(“the Company”), a biotech acceleration and commercial stage company focused on licensing and acquiring undervalued biomedical assets in the healthcare sector. CEO of the Company, Denis Corin, joined Stock Day host Everett Jolly. Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
Embed this episode
Ready to play
Q BioMed Inc. Discusses The Commercialization of Its FDA Approved Metastatic Bone Pain Drug with The Stock Day Podcast
No transcript for this episode yet
Similar Episodes
No similar episodes found.